Silence Therapeutics plc (SLN) Operating cash flow 2022–2025
Silence Therapeutics plc (SLN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$62.3MFY2025 · since FY2022: -$57.0M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.3M | +7.9% |
| FY2024 | -$67.6M | -36.8% |
| FY2023 | -$49.5M | +13.3% |
| FY2022 | -$57.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice